Skip to main content Back to Top
Advertisement

1/27/2020

Levetiracetam Injection

Products Affected - Description

    • Levetiracetam injection, Athenex, 10 mg/mL, 100 mL premixed bag, 10 count, NDC 70860-0603-82
    • Levetiracetam injection, Athenex, 15 mg/mL, 100 mL premixed bag, 10 count, NDC 70860-0604-82
    • Levetiracetam injection, AuroMedics, 100 mg/mL, 5 mL vial, 10 count, NDC 55150-0177-05
    • Levetiracetam injection, Pfizer, 100 mg/mL, 5 mL vial, 25 count, NDC 00409-1886-02
    • Levetiracetam injection, Sagent, 100 mg/mL, 5 mL vial, 10 count, NDC 25021-0780-05
    • Levetiracetam injection, X-Gen, 100 mg/mL, 5 mL vial, 10 count, NDC 39822-4000-01

Reason for the Shortage

    • American Regent did not provide a reason for the shortage.
    • Athenex did not provide a reason for the shortage.
    • AuroMedics did not provide a reason for the shortage.
    • Dr. Reddy's has levetiracetam injection available.
    • Fresenius Kabi has levetiracetam injection available.
    • Hikma has product available.
    • Mylan has levetiracetam injection available.
    • Pfizer did not provide a reason for the shortage.
    • Sagent did not provide a reason for the shortage.
    • Sun Pharma are not manufacturing levetiracetam injection at this time.
    • UCB has product available.
    • X-Gen did not provide a reason for the shortage.

Available Products

    • Keppra injection, UCB, 100 mg/mL, 5 mL vial, 10 count, NDC 50474-0002-63
    • Levetiracetam injection, Athenex, 5 mg/mL, 100 mL premixed bag, 10 count, NDC 70860-0602-82
    • Levetiracetam injection, AuroMedics, 10 mg/mL, 100 mL premixed bag, 10 count, NDC 55150-0247-47
    • Levetiracetam injection, AuroMedics, 15 mg/mL, 100 mL premixed bag, 10 count, NDC 55150-0248-47
    • Levetiracetam injection, AuroMedics, 5 mg/mL, 100 mL premixed bag, 10 count, NDC 55150-0246-47
    • Levetiracetam injection, Dr. Reddy's, 10 mg/mL, 100 mL premixed bag, 10 count, NDC 43598-0636-10
    • Levetiracetam injection, Dr. Reddy's, 15 mg/mL, 100 mL premixed bag, 10 count, NDC 43598-0637-10
    • Levetiracetam injection, Dr. Reddy's, 5 mg/mL, 100 mL premixed bag, 10 count, NDC 43598-0635-10
    • Levetiracetam injection, Fresenius Kabi, 100 mg/mL, 5 mL vial, 10 count, NDC 63323-0400-05
    • Levetiracetam injection, Hikma, 100 mg/mL, 5 mL vial, 25 count, NDC 00143-9673-25
    • Levetiracetam injection, Mylan, 10 mg/mL, 100 mL premixed bag, 10 count, NDC 67457-0265-10
    • Levetiracetam injection, Mylan, 15 mg/mL, 100 mL premixed bag, 10 count, NDC 67457-0266-10
    • Levetiracetam injection, Mylan, 5 mg/mL, 100 mL premixed bag, 10 count, NDC 67457-0255-10

Estimated Resupply Dates

    • Athenex has levetiracetam 10 mg/mL and 15 mg/mL 100 mL premixed bags on allocation.
    • AuroMedics has levetiracetam 100 mg/mL 5 mL vials on intermittent back order and the company is releasing product as it becomes available.
    • Pfizer has levetiracetam 100 mg/mL 5 mL vials available in limited supply.
    • Sagent has levetiracetam 100 mg/mL 5 mL vials on back order and the company cannot estimate a release date.
    • X-Gen has levetiracetam 100 mg/mL 5 mL vials on back order and the company cannot estimate a release date.

Updated

Updated January 27, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created May 14, 2015 by Jane Chandramouli, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins